BioCentury
ARTICLE | Company News

Celsis deal

August 10, 2009 7:00 AM UTC

Investment bank North Atlantic Value LLP will acquire supply/service company Celsis for 232.5p per share in cash, or about £54.5 million ($91.3 million). The price is a 14% premium to Celsis' close of 203.5p on July 31, the last trading day before the deal was announced. Celsis provides life science products and laboratory services, including microbial contamination detection, ADMET and analytical testing, to pharmaceutical and consumer products companies. The investor said the move will allow Celsis to become private and grow within a simplified and more efficient corporate structure. ...